ROFLUMILAST for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 149 adverse event reports in the FDA FAERS database where ROFLUMILAST was used for Psoriasis.
Most Reported Side Effects for ROFLUMILAST
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 569 | 21.1% | 568 | 8 |
| Dyspnoea | 433 | 16.0% | 7 | 191 |
| Chronic obstructive pulmonary disease | 292 | 10.8% | 26 | 158 |
| Diarrhoea | 265 | 9.8% | 6 | 82 |
| Off label use | 242 | 9.0% | 7 | 65 |
| Weight decreased | 224 | 8.3% | 8 | 74 |
| Nausea | 191 | 7.1% | 5 | 36 |
| Pneumonia | 176 | 6.5% | 7 | 123 |
| Headache | 166 | 6.2% | 2 | 26 |
| Malaise | 164 | 6.1% | 6 | 48 |
| Asthma | 158 | 5.9% | 0 | 76 |
| Drug ineffective | 156 | 5.8% | 1 | 30 |
| Decreased appetite | 151 | 5.6% | 6 | 44 |
| Insomnia | 151 | 5.6% | 2 | 29 |
| Cough | 140 | 5.2% | 0 | 40 |
Other Indications for ROFLUMILAST
Chronic obstructive pulmonary disease (945)
Product used for unknown indication (369)
Seborrhoeic dermatitis (61)
Emphysema (40)
Asthma (27)
Pseudomonas infection (27)
Dermatitis atopic (26)
Dyspnoea (22)
Eczema (15)
Bronchitis chronic (14)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)